Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD31 peptides in the treatment of thrombotic and autoimmune disorders

CD31 peptides in the treatment of thrombotic and autoimmune disorders

US Patent 9127086 · Granted Sep 8, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD31 shed as a molecular target for imaging of inflammation2021
CD31 shed as a molecular target for imaging of inflammation2021
CD31 peptides2020
CD31 peptides2020
Detection of platelet-derived shed CD312020
Detection of platelet-derived shed CD312020
CD31 peptides for the treatment of thrombotic or autoimmune disorders2019
CD31 peptides for the treatment of thrombotic or autoimmune disorders2019
Detection of shed CD31, diagnosis of atherothrombosis and autoimmune disorders, 2018
Detection of shed CD31, diagnosis of atherothrombosis and autoimmune disorders, 2018
Detection of platelet-derived shed CD312017
Detection of platelet-derived shed CD312017